Metropolitan Life Insurance Company (MetLife)’s Anika Therapeutics ANIK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-831	Closed	-$21.1K	–	141
2024 Q1	$21.1K	Hold	831	–	–	﹤0.01%	1833
2023 Q4	$18.8K	Hold	831	–	–	﹤0.01%	1943
2023 Q3	$15.5K	Hold	831	–	–	﹤0.01%	2012
2023 Q2	$21.6K	Hold	831	–	–	﹤0.01%	1888
2023 Q1	$23.9K	Sell	831 -235	-22%	-$6.99K	﹤0.01%	1789
2022 Q4	$31.6K	Hold	1,066	–	–	﹤0.01%	1761
2022 Q3	$25.4K	Hold	1,066	–	–	﹤0.01%	1896
2022 Q2	$23.8K	Hold	1,066	–	–	﹤0.01%	1960
2022 Q1	$26.8K	Sell	1,066 -3,582	-77%	-$109K	﹤0.01%	1955
2021 Q4	$167K	Hold	4,648	–	–	﹤0.01%	2148
2021 Q3	$198K	Hold	4,648	–	–	﹤0.01%	2078
2021 Q2	$201K	Hold	4,648	–	–	﹤0.01%	2137
2021 Q1	$190K	Hold	4,648	–	–	﹤0.01%	2055
2020 Q4	$210K	Hold	4,648	–	–	﹤0.01%	1904
2020 Q3	$164K	Hold	4,648	–	–	﹤0.01%	1903
2020 Q2	$175K	Sell	4,648 -493	-10%	-$16.2K	﹤0.01%	1889
2020 Q1	$149K	Hold	5,141	–	–	﹤0.01%	1774
2019 Q4	$267K	Hold	5,141	–	–	﹤0.01%	1719
2019 Q3	$282K	Hold	5,141	–	–	﹤0.01%	1642
2019 Q2	$209K	Hold	5,141	–	–	﹤0.01%	1866
2019 Q1	$155K	Hold	5,141	–	–	﹤0.01%	2068
2018 Q4	$173K	Hold	5,141	–	–	﹤0.01%	1921
2018 Q3	$217K	Hold	5,141	–	–	﹤0.01%	1952
2018 Q2	$165K	Hold	5,141	–	–	﹤0.01%	2063
2018 Q1	$256K	Hold	5,141	–	–	﹤0.01%	1738
2017 Q4	$277K	Sell	5,141 -5,276	-51%	-$292K	﹤0.01%	1681
2017 Q3	$604K	Hold	10,417	–	–	﹤0.01%	1558
2017 Q2	$514K	Hold	10,417	–	–	﹤0.01%	1669
2017 Q1	$453K	Hold	10,417	–	–	﹤0.01%	1714
2016 Q4	$510K	Hold	10,417	–	–	﹤0.01%	1712
2016 Q3	$498K	Hold	10,417	–	–	﹤0.01%	1711
2016 Q2	$559K	Sell	10,417 -287	-3%	-$13.5K	﹤0.01%	1617
2016 Q1	$479K	Hold	10,704	–	–	﹤0.01%	1594
2015 Q4	$408K	Buy	10,704 +358	+3%	+$13.7K	﹤0.01%	1753
2015 Q3	$329K	Sell	10,346 -396	-4%	-$13.8K	﹤0.01%	1919
2015 Q2	$355K	Sell	10,742 -379	-3%	-$13.5K	﹤0.01%	1991
2015 Q1	$458K	Hold	11,121	–	–	﹤0.01%	1604
2014 Q4	$453K	Hold	11,121	–	–	﹤0.01%	1829
2014 Q3	$408K	Hold	11,121	–	–	﹤0.01%	1846
2014 Q2	$515K	Hold	11,121	–	–	﹤0.01%	1812
2014 Q1	$457K	Hold	11,121	–	–	﹤0.01%	1869
2013 Q4	$424K	Hold	11,121	–	–	﹤0.01%	1922
2013 Q3	$266K	Hold	11,121	–	–	﹤0.01%	2202
2013 Q2	$189K	Buy	+11,121	New	+$160K	﹤0.01%	2387

Other funds holding ANIK

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ANIK Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Anika Therapeutics (ANIK) in Q2 2024, closing a stake of 831 shares — an estimated $21.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANIK in Q2 2013 and held it in 44 quarters. The position peaked at $604K in Q3 2017. 114 funds tracked by Wall St. Rank hold ANIK as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Anika Therapeutics position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 831 Anika Therapeutics shares in Q2 2024, an estimated $21.1K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Anika Therapeutics in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Anika Therapeutics position peaked at $604K in Q3 2017.
114 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.